in an acoustico-vestibular follow-up investigation of 91 four- to six-year-old children with birth weight below 2000 g , the same incidence of sensorineural hearing loss ( 19 % ) was found in 54 children treated with kanamycin in the neonatal period as in a group of 37 infants not treated with kanamycin .
C0008059
children
C0021270
infants